Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Joseph A. Pidala"'
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Hematopoietic cell transplantation (HCT) is the only potentially curative treatment option for many patients with hematologic malignancies. While HCT outcomes have improved drastically over the years, patients and clinicians continue to face numerous
Externí odkaz:
https://doaj.org/article/32f5245d0af244a3a0db4e3b2abc9401
Autor:
Yoshihiro Inamoto, Stephanie J. Lee, Lynn E. Onstad, Mary E.D. Flowers, Betty K. Hamilton, Madan H. Jagasia, Paul J. Martin, Steven Z. Pavletic, Joseph A. Pidala, Iskra Pusic, Georgia B. Vogelsang, Daniel Wolff, Paul A. Carpenter
Publikováno v:
Blood Advances, Vol 4, Iss 1, Pp 40-46 (2020)
Abstract: Implementation of the 2014 National Institutes of Health (NIH) response algorithm for joint/fascia graft-versus-host disease (GVHD) has identified real-world limits to its application. To refine the 2014 NIH response algorithm, we analyzed
Externí odkaz:
https://doaj.org/article/7b061d43ccbe4b15999f4b8b96d6b960
Autor:
Anita J. Kumar, Soyoung Kim, Michael T. Hemmer, Mukta Arora, Stephen R. Spellman, Joseph A. Pidala, Daniel R. Couriel, Amin M. Alousi, Mahmoud D. Aljurf, Jean-Yves Cahn, Mitchell S. Cairo, Corey S. Cutler, Shatha Farhan, Usama Gergis, Gregory A. Hale, Shahrukh K. Hashmi, Yoshihiro Inamoto, Rammurti T. Kamble, Mohamed A. Kharfan-Dabaja, Margaret L. MacMillan, David I. Marks, Hideki Nakasone, Maxim Norkin, Muna Qayed, Olle Ringden, Harry C. Schouten, Kirk R. Schultz, Melhem M. Solh, Takanori Teshima, Alvaro Urbano-Ispizua, Leo F. Verdonck, Robert Peter Gale, Betty K. Hamilton, Navneet S. Majhail, Alison W. Loren
Publikováno v:
Blood Advances, Vol 2, Iss 9, Pp 1022-1031 (2018)
Abstract: Optimal donor selection is critical for successful allogeneic hematopoietic cell transplantation (HCT). Donor sex and parity are well-established risk factors for graft-versus-host disease (GVHD), with male donors typically associated with
Externí odkaz:
https://doaj.org/article/eb6763f7bff54d2a9f6cf9c3ac09fd21
Autor:
Nahid Rashid, Mukta Arora, Najla El Jurdi, Lynn Onstad, Joseph A. Pidala, Mary E. Flowers, Stephanie J. Lee
Publikováno v:
Transplantation and Cellular Therapy. 29:367-374
Autor:
Vijaya Raj Bhatt, Stephanie J. Lee, Jaime M. Preussler, Gerhard C. Hildebrandt, Tao Wang, Monzr M. Al Malki, Amer Beitinjaneh, Dipenkumar Modi, Margaret L. MacMillan, Lazaros J. Lekakis, Sherif M. Badawy, Akshay Sharma, Siddhartha Ganguly, Carrie L. Kitko, Hemant S. Murthy, Richard T. Maziarz, Stephen R. Spellman, Karen Chen, Mukta Arora, Betty K. Hamilton, Joseph A. Pidala, Hongtao Liu
Publikováno v:
Transplantation and Cellular Therapy. 28:34-42
The effect of chronic graft-versus-host disease (cGVHD) on the risk of nonrelapse mortality (NRM) and relapse has not been specifically studied in older adults, who are increasingly undergoing allogeneic hematopoietic cell transplantation (alloHCT) a
Autor:
John Koreth, Alison W. Loren, Ryotaro Nakamura, Edmund K. Waller, Joseph A. Pidala, Marco Mielcarek, Cherie Tracy Ng, Lisette M Acevedo, Maple Fung, Joel Rothman, Stephen Connelly, Corey Cutler
Publikováno v:
Transplantation and Cellular Therapy. 29:S30-S31
Autor:
Filip Ionescu, Eloho Ajayi, Aamia Leach, Melissa Alsina, Nelli Bejanyan, Omar Castaneda, Hany Elmariah, Ciara Freeman, Doris K Hansen, Michael D Jain, Farhad Khimani, Aleksandr Lazaryan, Hien Liu, Frederick L. Locke, Asmita Mishra, Dr. Michael L. Nieder, Leonel Ochoa, Lia Elena Perez, Joseph A. Pidala, Rod Quilitz, Olga V Klinkova, Aliyah Baluch, Taiga Nishihori, Rawan G Faramand
Publikováno v:
Transplantation and Cellular Therapy. 29:S330-S331
Autor:
Hany Elmariah, Jongphil Kim, Kayla Reid, Christopher Cubitt, Jeffrey E Lancet, Andrew T Kuykendall, Rami Komrokji, David Sallman, Onyee Chan, Kendra Sweet, Albert Ribickas, Rawan G Faramand, Asmita Mishra, Farhad Khimani, Lia Elena Perez, Kedar Kirtane, Stephanie Dormesy, Debra Kessler, Doris K Hansen, Joseph A. Pidala, Claudio Anasetti, Ephraim J. Fuchs, Michael D Jain, Frederick L. Locke, Nelli Bejanyan, Amy E. DeZern
Publikováno v:
Transplantation and Cellular Therapy. 29:S204-S205
Autor:
Omar Albanyan, Syeda Mahrukh Naqvi, Qianxing Mo, Athena Belfon, Eric Gaskill, Taiga Nishihori, Rawan G Faramand, Aleksandr Lazaryan, Doris K Hansen, Farhad Khimani, Asmita Mishra, Dr. Michael L. Nieder, Lia Elena Perez, Hien Liu, Joseph A. Pidala, Claudio Anasetti, Frederick L. Locke, Nelli Bejanyan, Hany Elmariah
Publikováno v:
Transplantation and Cellular Therapy. 29:S113-S114
Autor:
Bronwen E. Shaw, Antonio Martin Jimenez-Jimenez, Linda J. Burns, Brent R. Logan, Farhad Khimani, Brian C. Shaffer, Nirav N. Shah, Alisha Mussetter, Xiao-Ying Tang, John M. McCarty, Asif Alavi, Nosha Farhadfar, Katarzyna Jamieson, Nancy M. Hardy, Hannah Choe, Richard F. Ambinder, Claudio Anasetti, Miguel-Angel Perales, Stephen R. Spellman, Alan Howard, Krishna V. Komanduri, Leo Luznik, Maxim Norkin, Joseph A. Pidala, Voravit Ratanatharathorn, Dennis L. Confer, Steven M. Devine, Mary M. Horowitz, Javier Bolaños-Meade
Publikováno v:
Transplantation and Cellular Therapy. 29:208.e1-208.e6
The use of Post-Transplant Cyclophosphamide (PTCy) as Graft Versus Host Disease (GVHD) prophylaxis has resulted in reductions in GVHD and improved outcomes in allogeneic hematopoietic cell transplant (HCT) using HLA-mismatched related donors. We repo